XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating activities:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 22,505 $ 7,940
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:    
Depreciation and amortization 20,893 20,969
Deferred income taxes and related valuation allowance (698) (1,235)
Net loss (gain) on sale of real estate, investments and other 852 (462)
Stock-based compensation 3,629 5,504
Amortization of deferred financing costs 860 867
Gain (Loss) on Extinguishment of Debt 0 (14,803)
Unrealized Gain (Loss) on Derivatives (714) 672
Gain (Loss) on Disposition of Property Plant Equipment (232) (375)
Gain (Loss) on Sale of Assets and Asset Impairment Charges (175) 0
Other Operating Activities, Cash Flow Statement 3,843 3,939
Changes in operating assets and liabilities, net of effects of business acquisitions:    
Trade accounts receivable 381 (1,709)
Inventories (30,754) (21,959)
Prepaid expenses and other 2,321 (2,779)
Increase (Decrease) in Other Operating Assets 24 42
Trade accounts payable (11,267) (6,274)
Increase (Decrease) in Accrued Liabilities (3,124) 1,908
Increase (Decrease) in Other Noncurrent Liabilities (2,545) (3,909)
Net cash provided by (used for) operating activities 6,149 17,942
INVESTING ACTIVITIES:    
Proceeds from Sale and Maturity of Marketable Securities 1,900 2,734
Payments to Acquire Marketable Securities (2,709) (4,768)
Payments to Acquire Property, Plant, and Equipment (5,288) (6,752)
Proceeds from Sale of Property, Plant, and Equipment 373 461
Proceeds from Equity Method Investment, Distribution, Return of Capital 313 0
Proceeds from Insurance Settlement, Investing Activities 0 482
Payments to Acquire Businesses, Net of Cash Acquired (1,616) (472,954)
Net cash provided by (used for) investing activities (7,027) (480,797)
FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock 621 1,412
Repayment of debt (20,264) (461,286)
Proceeds from Issuance of Long-term Debt 0 650,000
Proceeds from Issuance or Sale of Equity 0 207,000
Stock Issued During Period, Value, Stock Options Exercised 0 (25,292)
Proceeds from Derivative Instrument, Financing Activities 12,306 7,007
Payments for Derivative Instrument, Financing Activities (11,689) (6,927)
Payments of Dividends (4,001) (3,145)
Other (1,375) (1,909)
Net cash provided by (used for) financing activities (24,402) 366,860
Effect of exchange rate changes on cash (1,245) (821)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (26,525) (96,816)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents 89,115 105,561
Supplementary cash flow data:    
Interest Paid, Excluding Capitalized Interest, Operating Activities 12,045 8,666
Income taxes paid, net of refunds 10,271 2,910
Restricted Cash $ 250 $ 250